REVOSHIELD+
Live / Applied — Statement of use — registration review complete (as of 04 Nov 2026)
What this means for you
Not registered yet, but its 20 Aug 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99347237
- Mark type
- Word mark
- Filed
- 20 Aug 2025
- Published for opposition
- 10 Mar 2026
- Attorney of record
- William H. Quirk
Goods and services
- Class 005 — Pharmaceuticals: Dual layer amnion patch made from biological materials used for general orthopedic, reconstructive and spinal procedures, as well as for various types of wound care and burn treatments
Owner
- RevoGen Biologics, LLC, San Antonio, TX, US
- RevoGen Biologics, LLC, San Antonio, TX, US
Prior registrations
Prosecution history
- 04 Nov 2026 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 04 Nov 2026 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 27 Oct 2026 — STATEMENT OF USE PROCESSING COMPLETE
- 23 Oct 2026 — USE AMENDMENT FILED
- 23 Oct 2026 — TEAS STATEMENT OF USE RECEIVED
- 05 May 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 10 Mar 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 10 Mar 2026 — PUBLISHED FOR OPPOSITION
- 04 Mar 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Feb 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Feb 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Feb 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Feb 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 09 Jan 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 09 Jan 2026 — NON-FINAL ACTION E-MAILED